Compound · GHRH analog and ghrelin receptor agonist blend
Tesamorelin + Ipamorelin
Tesamorelin · Ipamorelin
FormatSignalis Bio lyophilized vial with 10 mg + 5 mg declared content, made in the United States and designated research grade.

What science explores · not a promise
- Endocrine signaling
- Body composition
- Adipose tissue biology
What it is
Tesamorelin + Ipamorelin is a blend of two synthetic peptides investigated for their interaction with the growth hormone axis. Tesamorelin is a forty-four-amino-acid GHRH analog with a modification at its initial end. Ipamorelin is a five-amino-acid peptide acting at the ghrelin receptor. The blend brings together distinct receptor pathways; it does not directly contain growth hormone. Research on each component supplies context but does not automatically establish the characteristics of a combined formulation. Molecular identity, clinical evidence on individual components, and documentation for the commercial material must be distinguished from one another.
This material is research grade and is not a medicine. Published observations depend on the experimental system and its controls; they are not a promise for people. Documentation of identity, purity, and origin must be evaluated independently of any scientific hypothesis or proposed biological mechanism.
Origin
Tesamorelin comes from synthetic design of human GHRH analogs, developed in industrial and clinical programs during the late twentieth and early twenty-first centuries. Ipamorelin was described in industrial research during the 1990s. The blend is a catalog formulation rather than an isolated natural substance, and its components have distinct research histories.
How it is studied
Cellular and animal endocrine models measure receptor activation, growth hormone, and IGF-1. Studies of tesamorelin alone also examine adipose tissue imaging and metabolic markers. Human data on this specific blend are limited; evidence on one component does not automatically validate its combination with another peptide or establish the properties of a catalog batch. These studies make no promises of personal effects. Available human information has limitations and does not amount to evidence for this commercial batch. Interpretation requires reviewing controls, reproducibility, analytical identity, and differences between models before drawing scientific conclusions about the observations.
Related lessons
Dr. Peptide is a virtual presenter created with artificial intelligence; she is not a healthcare professional. This content is educational and is not medical advice, diagnosis or treatment. Decisions about your health belong with a licensed professional. Research-grade products; sale to adults 18+ only.
Follow us on Instagram · @Signalisbio

